Analyst Ratings for DexCom (DXCM)
DXCM Rating Summary
DXCM Price Target Summary
- Highest: $115.00 (Barclays)
- Lowest: $75.00 (Morgan Stanley)
- Average: $92.22
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$92.22 (+18.3%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$92.22 (+18.3%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/6/2026 | Barclays | Matt Miksic | New Coverage | Overweight (N/A) |
115.00 (N/A) |
86.90 (77.94) |
-10.31% | Details |
| 7/28/2026 | UBS | Patrick Wood | New Coverage | Buy (N/A) |
96.00 (N/A) |
73.37 (77.94) |
6.23% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
